{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:29:07Z","timestamp":1787056147961,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","award":["2022A1515012439"],"award-info":[{"award-number":["2022A1515012439"]}],"id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112707","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:49:04Z","timestamp":1783007344000},"page":"112707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ILF3 promotes proliferation and invasion of hepatocellular carcinoma cells through STAT3 phosphorylation and formation of an endogenous complex with SRPK1"],"prefix":"10.1016","volume":"147","author":[{"given":"Jianjian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangyao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112707_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112707_bb0010","first-page":"506","article-title":"RNA-binding proteins in cancer: old players and new actors, trends","volume":"3","author":"Pereira","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cellsig.2026.112707_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112707_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cellsig.2026.112707_bb0025","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112707_bb0030","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112707_bb0035","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2026.112707_bb0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112707_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112707_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/wrna.1270","article-title":"Ilf3 and NF90 functions in RNA biology","volume":"6","author":"Castella","year":"2015","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"key":"10.1016\/j.cellsig.2026.112707_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","article-title":"How RNA-binding proteins interact with RNA: molecules and mechanisms","volume":"78","author":"Corley","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112707_bb0060","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1038\/onc.2012.414","article-title":"Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression","volume":"32","author":"Hu","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112707_bb0065","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.18632\/aging.204051","article-title":"Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K\/AKT\/mTOR signaling pathway","volume":"14","author":"Sun","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2026.112707_bb0070","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1038\/onc.2014.373","article-title":"Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability","volume":"34","author":"Jiang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112707_bb0075","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s13577-021-00608-x","article-title":"Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m6A-dependent manner","volume":"34","author":"Bo","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.cellsig.2026.112707_bb0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.joim.2025.06.003","article-title":"Integrated-omics analysis defines subtypes of hepatocellular carcinoma based on circadian rhythm","volume":"23","author":"Li","year":"2025","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.cellsig.2026.112707_bb0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/path.4846","article-title":"The many faces of SRPK1","volume":"241","author":"Bullock","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellsig.2026.112707_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00412-013-0407-z","article-title":"Regulation of splicing by SR proteins and SR protein-specific kinases","volume":"122","author":"Zhou","year":"2013","journal-title":"Chromosoma"},{"key":"10.1016\/j.cellsig.2026.112707_bb0095","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2017.10.037","article-title":"Post-transcriptional regulation of De novo lipogenesis by mTORC1-S6K1-SRPK2 signaling","volume":"171","author":"Lee","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112707_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2016.03.013","article-title":"SRPK1 inhibition in prostate cancer: a novel anti-angiogenic treatment through modulation of VEGF alternative splicing","volume":"107","author":"Mavrou","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112707_bb0105","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2015.318","article-title":"Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes","volume":"35","author":"Sveen","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112707_bb0110","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s11010-022-04456-7","article-title":"Serine-arginine protein kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis","volume":"477","author":"Duggan","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2026.112707_bb0115","article-title":"Identifying C1orf122 as a potential HCC exacerbated biomarker dependently of SRPK1 regulates PI3K\/AKT\/GSK3\u03b2 signaling pathway","volume":"13","author":"Cai","year":"2026","journal-title":"Genes Dis."},{"key":"10.1016\/j.cellsig.2026.112707_bb0120","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2026.112707_bb0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.cellsig.2026.112707_bb0130","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2026.112707_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2026.112707_bb0140","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2026.112707_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cellsig.2026.112707_bb0150","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","article-title":"Role of epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"65","author":"Giannelli","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112707_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112707_bb0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s43657-024-00182-w","article-title":"Cell function experiments and bioinformatics analysis jointly revealed the antineoplastic effect of lumican on hepatocellular carcinoma","volume":"5","author":"Zhou","year":"2025","journal-title":"Phenomics"},{"key":"10.1016\/j.cellsig.2026.112707_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41422-019-0257-1","article-title":"ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer","volume":"30","author":"Li","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cellsig.2026.112707_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112707_bb0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.molcel.2014.03.007","article-title":"Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of akt","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112707_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.124","article-title":"STAT3 pathway in cancers: past, present, and future","volume":"3","author":"Wang","year":"2022","journal-title":"MedComm"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:42:29Z","timestamp":1787053349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0898656826003621"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112707","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ILF3 promotes proliferation and invasion of hepatocellular carcinoma cells through STAT3 phosphorylation and formation of an endogenous complex with SRPK1","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112707"}}